Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Assessing Mobile Apps for Adult ADHD
- Conditions
- Attention Deficit Hyperactivity Disorder
- First Posted Date
- 2024-02-13
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Think Now Incorporated
- Target Recruit Count
- 140
- Registration Number
- NCT06256003
- Locations
- 🇺🇸
University of California Berkeley, Berkeley, California, United States
🇺🇸UCLA Semel Institute, Los Angeles, California, United States
Neurophysiological Attention Test (NAT) for Objective Assessment of Adult ADHD
- Conditions
- Attention Deficit Hyperactivity Disorder
- First Posted Date
- 2016-04-29
- Last Posted Date
- 2018-09-19
- Lead Sponsor
- Think Now Incorporated
- Target Recruit Count
- 258
- Registration Number
- NCT02756286
- Locations
- 🇺🇸
University of California Berkeley, Berkeley, California, United States
🇺🇸UCLA Semel Institute, Los Angeles, California, United States
🇺🇸Oregon Health & Science University, Portland, Oregon, United States
Training Attentional Awareness and Control in ADHD
- Conditions
- Attention Deficit Hyperactivity Disorder
- First Posted Date
- 2015-07-03
- Last Posted Date
- 2019-07-10
- Lead Sponsor
- Think Now Incorporated
- Target Recruit Count
- 107
- Registration Number
- NCT02489279
- Locations
- 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States
Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
- Conditions
- Attention Deficit Hyperactivity Disorder (ADHD)
- First Posted Date
- 2015-04-03
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- Think Now Incorporated
- Target Recruit Count
- 80
- Registration Number
- NCT02407496
- Locations
- 🇺🇸
UCLA Semel Institute, Los Angeles, California, United States